SSRI treatment modifies the effects of maternal inflammation on in utero physiology and offspring neurobiology

• Published in: Brain, behavior, and immunity Vol. 108; pp. 80 - 97
• Main Authors: Zengeler, Kristine E., Shapiro, Daniel A., Bruch, Katherine R., Lammert, Catherine R., Ennerfelt, Hannah, Lukens, John R.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01.02.2023
• Subjects: Animals; Female; Humans; Inflammation - metabolism; Male; Maternal immune activation; Maternal-fetal interface; Mice; Microglia; Neurobiology; Neurodevelopment; Neuroimmunology; Placenta; Placenta - metabolism; Pregnancy; Prenatal Exposure Delayed Effects; Selective serotonin reuptake inhibitor; Serotonin - metabolism; ADD; BBB; E; polyI:C; SLC; Selective serotonin reuptake inhibitor; IFN; P; MFI; scRNA-seq; Maternal-fetal interface; RNA-seq; TLR; Neuroimmunology; dNK; hpi; Maternal immune activation; MIA; DEG; MACS; GO; GSEA; IGF; i.p; PCA; Microglia; SSRI; Placenta; Neurodevelopment; USV; MAO
• ISSN: 0889-1591; 1090-2139
• DOI: 10.1016/j.bbi.2022.10.024

•Maternal immune activation (MIA) elicits an inflammatory transcriptional response at the maternal-fetal interface (MFI).•Baseline sex differences in the MFI transcriptome are dampened after resolution of the MIA inflammatory response.•The MFI response to MIA is reshaped when combined with selective serotonin reuptake inhibitor (SSRI) treatment.•Offspring neurobiology is impacted by MIA and SSRI exposure potentiates the embryonic brain response to MIA. Perturbations to the in utero environment can dramatically change the trajectory of offspring neurodevelopment. Insults commonly encountered in modern human life such as infection, toxins, high-fat diet, prescription medications, and others are increasingly linked to behavioral alterations in prenatally-exposed offspring. While appreciation is expanding for the potential consequence that these triggers can have on embryo development, there is a paucity of information concerning how the crucial maternal-fetal interface (MFI) responds to these various insults and how it may relate to changes in offspring neurodevelopment. Here, we found that the MFI responds both to an inflammatory state and altered serotonergic tone in pregnant mice. Maternal immune activation (MIA) triggered an acute inflammatory response in the MFI dominated by interferon signaling that came at the expense of ordinary development-related transcriptional programs. The major MFI compartments, the decidua and the placenta, each responded in distinct manners to MIA. MFIs exposed to MIA were also found to have disrupted sex-specific gene expression and heightened serotonin levels. We found that offspring exposed to MIA had sex-biased behavioral changes and that microglia were not transcriptionally impacted. Moreover, the combination of maternal inflammation in the presence of pharmacologic inhibition of serotonin reuptake further transformed MFI physiology and offspring neurobiology, impacting immune and serotonin signaling pathways alike. In all, these findings highlight the complexities of evaluating diverse environmental impacts on placental physiology and neurodevelopment.